1Kroschinsky F, Weise M, Illmer T, et al. Outcome end prognostic features of intensive care unit treatment in patients with hematological malignancies. Intensive Care Med, 2002,28:1294.
2Ewig S, Torres A, Riquelme R, et al. Pulmonary complications in patients with haernatological malignancies treated at a respiratory ICU. Eur Respir J. 1998,12:116.
5Slutsky AS,Imai Y,Ventilator-induced lung injury,cytokines,PEEPand mortality,implicaction for practice and for clinical trials(J).In-tensive Care Med,2003,29:1218-1221.
6Sun B,Rider E,Ikegami M,et al.Antenatal ambroxol effects on sur-factant pool size and postnatal lung function in pretern ventilated rab-bits(J).Biol Neonate,1992,62:55-62.
7Murphy CV, Schramm GE, Doherty JA, et al. The impor- tance of fluid management in acute lung injury secondary to septic shock [ J ]. Chest,2009,136 ( 1 ) : 102 - 109.
9Williams JP, Mcbride WH. After the bomb drops: a new look at radiation - induced multiple organ dysfunction syn- drome(MODS) [ J]. Int J Radiat Biol, 2011,87 (8) : 851 - 868.
10Ryter SW, Choi AM. Heme oxygenase - 1/carbon monox- ide:novel therapeutic strategies in critical care medicine [ J]. Curr Drug Targets ,2010,11 (12) : 1485 - 1494.
